Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,330.20
+5.20 (0.39%)
Mar 10, 2026, 11:50 AM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.07 trillion as of March 9, 2026. Its market cap has decreased by -9.19% in one year.
Market Cap
1.07T
Enterprise Value
970.02B
Revenue
279.67B
Ranking
n/a
PE Ratio
23.56
Stock Price
1,330.20
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.07T, an increase of 70,608.06%. That is a compound annual growth rate of 24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.07T | -12.33% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.68T |
| Zydus Lifesciences | 918.74B |
| Mankind Pharma | 902.80B |
| Aurobindo Pharma | 715.49B |
| Alkem Laboratories | 661.19B |
| Glenmark Pharmaceuticals | 599.51B |
| Laurus Labs | 554.00B |
| Ipca Laboratories | 379.08B |